Filter posts

2012 BIO International Convention: Academic and Tech Transfer Community

Universities have historically been on the front lines of translating innovative research into novel medicines …

Mayo v. Prometheus: Thought Leaders Express Concern and Evaluate the Impact

The Mayo v. Prometheus event hosted at George Washington School of Law with the Biotechnology …

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward is a public round-table event hosted …

Congressional Hearing on International Patent Issues: BIO Submits Comments

The House Judiciary Committee conducted a hearing on World IP Day on “International Patent Issues: …

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact …

New Patented Drugs Save Us All Money and Help Those in Dire Need

New patented drugs actually save the United States and its citizens lots of money. In …

India Compulsory License: A Times of India Article Says It's Not Helping the Poor

India recently issued a compulsory license on Bayer’s liver and kidney cancer drug (Sorafenib) with …

Patent "Ever-Greening": Novartis Confronts Patent Myth in India

India’s ‘increased efficacy’ patentability requirement for medicines prevents an improved form of a known drug …

BIO IP Counsels Conference Agenda Topics

Join us in Austin for BIO’s Intellectual Property Counsels Committee Conference on April 16-18.  Agenda …

PTO Genetic Testing Study: What's Patents Got to Do with It

The USPTO held a hearing on February 16 to collect testimony from interested parties to …